MANKIND.NS Mankind Pharma Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 190737 | 104593 | 54.84% |
| 2026-08-27 | 322167 | 209735 | 65.10% |
| 2026-08-26 | 513001 | 246659 | 48.08% |
| 2026-08-25 | 415562 | 303588 | 73.05% |
| 2026-08-24 | 130471 | 64458 | 49.40% |
| 2026-08-21 | 343261 | 231483 | 67.44% |
| 2026-08-20 | 307625 | 199080 | 64.72% |
| 2026-08-19 | 370273 | 140646 | 37.98% |
| 2026-08-18 | 366118 | 212110 | 57.93% |
| 2026-08-17 | 810528 | 598767 | 73.87% |
| 2026-08-14 | 465158 | 197805 | 42.52% |
| 2026-08-13 | 129086 | 69457 | 53.81% |
| 2026-08-12 | 754503 | 538826 | 71.41% |
| 2026-08-11 | 229702 | 129238 | 56.26% |
| 2026-08-10 | 230964 | 128177 | 55.50% |
| 2026-08-07 | 167663 | 90085 | 53.73% |
| 2026-08-06 | 241909 | 147991 | 61.18% |
| 2026-08-05 | 157619 | 79850 | 50.66% |
| 2026-08-04 | 346444 | 207565 | 59.91% |
| 2026-08-03 | 639674 | 361571 | 56.52% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers MANKIND.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 09 Feb 2024 | Sheetal Arora | Promoters | Sell | Market Sale | 1817070 | 3829202464 | 4.81% | XBRL |
| 09 Feb 2024 | Puja Juneja | Promoter Group | Sell | Market Sale | 2271336 | 4786499920 | 2.88% | XBRL |
| 09 Feb 2024 | Arjun Juneja | Promoter Group | Sell | Market Sale | 2401128 | 5060017091 | 2.04% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers MANKIND.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
ROCE Trajectory
Earnings Quality
No persistent gap detected
Net Profit CAGR 14.27% vs CFO CAGR 19.84% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit -3.70% vs CFO +29.33%
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q3 FY2023-24 | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2,606.96 Cr. | ₹2,441.10 Cr. | ₹2,893.42 Cr. | ₹3,076.51 Cr. | ₹3,230.00 Cr. | ₹3,570.35 Cr. | ₹3,697.16 Cr. | ₹3,567.20 Cr. | ₹3,442.93 Cr. | ₹4,030.59 Cr. | RevenueFromOperations |
| Net Profit | ₹453.76 Cr. incl. minority ₹459.81 Cr. | ₹471.24 Cr. incl. minority ₹476.59 Cr. | ₹536.49 Cr. incl. minority ₹543.07 Cr. | ₹653.47 Cr. incl. minority ₹658.88 Cr. | ₹380.23 Cr. incl. minority ₹384.52 Cr. | ₹438.32 Cr. incl. minority ₹444.62 Cr. | ₹511.51 Cr. incl. minority ₹520.18 Cr. | ₹408.75 Cr. incl. minority ₹413.88 Cr. | ₹554.35 Cr. incl. minority ₹559.42 Cr. | ₹574.09 Cr. | ProfitOrLossAttributableToOwnersOfParent |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers MANKIND.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 19129300000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 412800000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 71396900000.0 |
| CurrentLiabilities | 65072500000.0 |
| EquityAttributableToOwnersOfParent | 163003400000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | 63115400000.0 |